Sigma Investment Counselors Inc Eli Lilly & CO Transaction History

Sigma Investment Counselors Inc

$2.05 Billion
Q3 2024

A detailed history of Sigma Investment Counselors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Sigma Investment Counselors Inc holds 1,341 shares of LLY stock, worth $1.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,341

Previous 1,225 9.47%

Holding current value

$1.1 Million

Previous $1.11 Million 7.12%

% of portfolio

0.06%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$772.14 - $960.02 $89,568 - $111,362	116 Added 9.47%	1,341 $1.19 Million
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $32,619 - $40,906	-45 Reduced 3.54%	1,225 $1.11 Million
Q1 2024 Apr 25, 2024	SELL	$592.2 - $792.28 $547,785 - $732,859	-925 Reduced 42.14%	1,270 $988,000
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $17,331 - $20,431	-33 Reduced 1.48%	2,195 $1.28 Million
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $32,167 - $44,348	74 Added 3.44%	2,228 $1.2 Million
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $19,290 - $25,793	-55 Reduced 2.49%	2,154 $1.01 Million
Q1 2023 Apr 28, 2023	SELL	$310.63 - $364.82 $17,084 - $20,065	-55 Reduced 2.43%	2,209 $758,000
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $47,910 - $55,825	149 Added 7.04%	2,264 $0
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $10,376 - $11,825	-35 Reduced 1.63%	2,115 $684,000
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $16,445 - $19,308	59 Added 2.82%	2,150 $697,000
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $7,275 - $9,041	-31 Reduced 1.46%	2,091 $599,000
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $18,212 - $22,602	81 Added 3.97%	2,122 $586,000
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $26,592 - $32,725	-120 Reduced 5.55%	2,041 $472,000
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $32,864 - $42,544	-200 Reduced 8.47%	2,161 $404,000
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $99,280 - $131,371	761 Added 47.56%	2,361 $399,000
Q3 2020 Oct 20, 2020	SELL	$146.22 - $169.13 $39,625 - $45,834	-271 Reduced 14.48%	1,600 $237,000
Q4 2019 Jan 21, 2020	SELL	$106.92 - $132.43 $1,176 - $1,456	-11 Reduced 0.58%	1,871 $246,000
Q3 2019 Oct 18, 2019	SELL	$106.79 - $116.16 $3,417 - $3,717	-32 Reduced 1.67%	1,882 $210,000
Q2 2019 Jul 23, 2019	BUY	$110.79 - $129.32 $3,545 - $4,138	32 Added 1.7%	1,914 $212,000
Q4 2018 Feb 01, 2019	BUY	$105.9 - $118.64 $1,588 - $1,779	15 Added 0.8%	1,882 $218,000
Q3 2018 Oct 23, 2018	BUY	$85.86 - $107.31 $160,300 - $200,347	1,867 New	1,867 $200,000

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $778B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Investment Counselors Inc with notifications on news.

Account

Sigma Investment Counselors Inc Eli Lilly & CO Transaction History